Effectiveness of Nivolumab on Sarcomatoid Malignant Pleural Mesothelioma With Eosinophilia and Eosinophilic Pleural Effusion

J Thorac Oncol. 2019 Nov;14(11):e251-e253. doi: 10.1016/j.jtho.2019.06.007.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Carcinosarcoma / blood
  • Carcinosarcoma / drug therapy*
  • Carcinosarcoma / pathology
  • Eosinophilia / blood
  • Eosinophilia / drug therapy*
  • Eosinophilia / pathology
  • Humans
  • Lung Neoplasms / blood
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Male
  • Mesothelioma / blood
  • Mesothelioma / drug therapy*
  • Mesothelioma / pathology
  • Mesothelioma, Malignant
  • Nivolumab / therapeutic use*
  • Pleural Effusion, Malignant / blood
  • Pleural Effusion, Malignant / drug therapy*
  • Pleural Effusion, Malignant / pathology
  • Prognosis

Substances

  • Antineoplastic Agents, Immunological
  • Nivolumab